1. Home
  2. BEEP vs VRCA Comparison

BEEP vs VRCA Comparison

Compare BEEP & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobile Infrastructure Corporation

BEEP

Mobile Infrastructure Corporation

N/A

Current Price

$2.62

Market Cap

106.1M

Sector

Finance

ML Signal

N/A

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

N/A

Current Price

$4.52

Market Cap

88.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BEEP
VRCA
Founded
2015
2013
Country
United States
United States
Employees
18
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.1M
88.0M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
BEEP
VRCA
Price
$2.62
$4.52
Analyst Decision
Buy
Strong Buy
Analyst Count
3
7
Target Price
$5.83
★ $13.83
AVG Volume (30 Days)
17.2K
★ 38.9K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
$35,075,000.00
★ $35,577,000.00
Revenue This Year
$1.47
N/A
Revenue Next Year
$11.40
$58.01
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 370.22
52 Week Low
$1.29
$3.28
52 Week High
$3.78
$9.82

Technical Indicators

Market Signals
Indicator
BEEP
VRCA
Relative Strength Index (RSI) 48.76 N/A
Support Level $2.73 N/A
Resistance Level $2.94 N/A
Average True Range (ATR) 0.09 0.00
MACD -0.03 0.00
Stochastic Oscillator 33.33 0.00

Price Performance

Historical Comparison
BEEP
VRCA

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focus on acquiring, owning and optimizing parking facilities and related infrastructure, including parking lots, parking garages, and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provides access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: